company background image
OPTOMED logo

Optomed Oyj HLSE:OPTOMED Stock Report

Last Price

€3.99

Market Cap

€70.9m

7D

-1.7%

1Y

-3.4%

Updated

25 Apr, 2024

Data

Company Financials +

Optomed Oyj Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Optomed Oyj
Historical stock prices
Current Share Price€3.99
52 Week High€4.67
52 Week Low€2.31
Beta2.26
1 Month Change0.25%
3 Month Change3.37%
1 Year Change-3.39%
3 Year Change-58.95%
5 Year Changen/a
Change since IPO-12.88%

Recent News & Updates

Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 25% Share Price Boost

Mar 22
Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 25% Share Price Boost

Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts

Feb 18
Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts

Recent updates

Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 25% Share Price Boost

Mar 22
Market Might Still Lack Some Conviction On Optomed Oyj (HEL:OPTOMED) Even After 25% Share Price Boost

Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts

Feb 18
Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts

Market Cool On Optomed Oyj's (HEL:OPTOMED) Revenues

Dec 21
Market Cool On Optomed Oyj's (HEL:OPTOMED) Revenues

Is Optomed Oyj (HEL:OPTOMED) Using Debt In A Risky Way?

Nov 15
Is Optomed Oyj (HEL:OPTOMED) Using Debt In A Risky Way?

Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts

Aug 09
Earnings Update: Optomed Oyj (HEL:OPTOMED) Just Reported And Analysts Are Trimming Their Forecasts

Investors Continue Waiting On Sidelines For Optomed Oyj (HEL:OPTOMED)

Jun 01
Investors Continue Waiting On Sidelines For Optomed Oyj (HEL:OPTOMED)

Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?

Oct 27
Does Optomed Oyj (HEL:OPTOMED) Have A Healthy Balance Sheet?

Is Optomed Oyj (HEL:OPTOMED) A Risky Investment?

Apr 23
Is Optomed Oyj (HEL:OPTOMED) A Risky Investment?

Optomed Oyj (HEL:OPTOMED) Has Debt But No Earnings; Should You Worry?

Aug 05
Optomed Oyj (HEL:OPTOMED) Has Debt But No Earnings; Should You Worry?

The Optomed Oyj (HEL:OPTOMED) Share Price Has Gained 14% And Shareholders Are Hoping For More

Feb 16
The Optomed Oyj (HEL:OPTOMED) Share Price Has Gained 14% And Shareholders Are Hoping For More

Shareholder Returns

OPTOMEDFI Medical EquipmentFI Market
7D-1.7%-2.8%-0.8%
1Y-3.4%-36.4%-15.7%

Return vs Industry: OPTOMED exceeded the Finnish Medical Equipment industry which returned -35.3% over the past year.

Return vs Market: OPTOMED exceeded the Finnish Market which returned -13.6% over the past year.

Price Volatility

Is OPTOMED's price volatile compared to industry and market?
OPTOMED volatility
OPTOMED Average Weekly Movement6.2%
Medical Equipment Industry Average Movement5.9%
Market Average Movement4.6%
10% most volatile stocks in FI Market7.7%
10% least volatile stocks in FI Market3.2%

Stable Share Price: OPTOMED has not had significant price volatility in the past 3 months.

Volatility Over Time: OPTOMED's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Finnish stocks.

About the Company

FoundedEmployeesCEOWebsite
2004114Juho Himbergwww.optomed.com

Optomed Oyj, together with its subsidiaries, manufactures and sells handheld fundus cameras in Finland and internationally. It operates in two segments, Devices and Software. The company develops, manufactures, and sells fundus cameras for ophthalmologists, pediatricians, endocrinologists, neurologists, and primary care professionals; and provides professional IT consulting services for government institutions.

Optomed Oyj Fundamentals Summary

How do Optomed Oyj's earnings and revenue compare to its market cap?
OPTOMED fundamental statistics
Market cap€70.93m
Earnings (TTM)-€4.44m
Revenue (TTM)€15.10m

4.7x

P/S Ratio

-16.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
OPTOMED income statement (TTM)
Revenue€15.10m
Cost of Revenue€4.86m
Gross Profit€10.24m
Other Expenses€14.68m
Earnings-€4.44m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 07, 2024

Earnings per share (EPS)-0.25
Gross Margin67.83%
Net Profit Margin-29.41%
Debt/Equity Ratio16.5%

How did OPTOMED perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.